Stay updated on Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial

Sign up to get notified when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added B-cell chronic lymphocytic leukemia as a keyword/condition term and included Genetic and Rare Diseases Information Center as a resources entry. These updates improve searchability and provide readers with additional background information.
    Difference
    0.2%
    Check dated 2026-04-02T00:32:32.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's revision history now shows the addition of v3.5.0 and the removal of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:54:51.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:43:51.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. The prior funding-status notice and Revision: v3.4.1 were removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:43:18.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added a government funding notice noting potential delays in updates and the NIH Clinical Center's status, with guidance to check cc.nih.gov and opm.gov. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T00:00:41.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle and new metadata fields: Last Update Submitted that Met QC Criteria and Last Update Posted, along with a revision indicator: Revision: v3.4.0. Older items Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.3%
    Check dated 2026-01-28T00:18:11.000Z thumbnail image

Stay in the know with updates to Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.